Production of adenoviral vectors and its recovery

Process Biochemistry

Volumn 42, Issue 7, 2007, Pages 1107-1113

  Negrete, Alejandro ^a   Ling, Tau Chuan ^a   Lyddiatt, Andrew ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Adenoviral vectors; ATPS; HEK 293; Recovery; Yield

Indexed keywords

BIOACTIVITY; BIOMATERIALS; GENES; PH EFFECTS;

ADENOVIRAL VECTORS; AQUEOUS TWO-PHASE SYSTEM (ATPS); GENE THERAPY; INOCULATION;

PROTEINS;

ADENOVIRIDAE;

EID: 34347213393     PISSN: 13595113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.procbio.2007.05.004     Document Type: Article

References (34)

1. Berkner K.L. Expression of heterologous sequences in adenoviral vectors. Curr Top Microbiol 158 (1992) 39-66
2. Ferreira T.B., Alves P.M., Aunins J.G., and Carrondo M.J.T. Use of adenoviral vectors as veterinary vaccines. Gene Ther 12 (2005) S73-S83
3. Majhen D., and Ambriovic-Ristov A. Adenoviral vectors-how to use them in cancer gene therapy?. Virus Res 119 (2006) 121-133
4. Hitt M.M., Addison C.L., and Graham F.L. Human adenovirus vectors for gene transfer into mammalian cells. Adv Pharmacol 40 (1997) 137-206
5. Gerard R.D., and Meidell R.S. Adenovirus-mediated gene transfer. Trends Cardiovas Med 5 (1993) 171-177
6. Peixoto C., Ferreira T.B., Carrondo M.J.T., Cruz P.E., and Alves P.M. Purification of adenoviral vectors using expanded bed chromatography. J Virol Methods 132 (2006) 121-126
7. Zhang C., Ferreira T.B., Cruz P.E., Alves P.M., Haury M., and Carrondo M.J.T. The importance of 293 cell cycle phase on adenovirus vector production. Enzyme Microb Tech 39 (2006) 1328-1332
8. Nadeau I., Garnier A., Côté J., Massie B., Chavarie C., and Kamen A. Improvement of recombinant protein production with the human adenovirus/293S expression system using fed-batch strategies. Biotechnol Bioeng 51 (1996) 613-623
9. Krisher K.K., and Menegus M.A. Evaluation of three types of cell culture for recovery of adenovirus from clinical specimens. J Clin Microbiol 25 (1987) 1323-1324
10. Smith A.E. Viral vectors in gene therapy. Annu Rev Microbiol 49 (1995) 807-838
11. Graham F.L., Smiley J., Russell W.C., and Nairn R. Characterization of a human cell line transformed by DNA from adenovirus 5. J Gen Virol 36 (1977) 59-72
12. Jani A., Lochmüller H., Acsadi G., Simoneau M., Huard J., and Garnier A. Generation, validation, and large scale production of adenoviral recombinants with large size inserts such as a 6.3 kb human distrophin cDNA. J Virol 64 (1997) 111-124
13. Monica T.J., Montgomery T., Ayala J.L., Schoofs G.M., Whiteley E.M., Roth G., et al. Monitoring adenovirus infections with on-line and off-line methods. Biotechnol Progr 16 (2000) 866-871
14. Côté J., Garnier A., Massie B., and Kamen A. Serum-free production of recombinant proteins and adenoviral vectors by 293SF-3F6 cells. Biotechnol Bioeng 59 (1998) 567-575
15. Epstein D.A., Godwin G.P., Gruber D.F., and Grefrath P.L. Serum-free suspension culture of 293 cells. Focus 21 (1999) 22-24
16. Waymouth C. Preparation and use of serum-free culture media (1984), Alan R. Liss, Inc, New York p. 23-68
17. Nadeau I., Gilbert P.A., Jacob D., Perrier M., and Kamen A. Low-protein medium affects the 293SF central metabolism during growth and infection with adenovirus. Biotechnol Bioeng 77 (2002) 91-104
18. Laver W.G., Banfield S., Younghusband H., and Wrigley N.G. Purification and properties of chick embryo lethal orphan virus (an avian adenovirus). Virology 45 (1971) 598-614
19. ASTWG. Adenovirus Standard Working Group. March 25, 1-8. The Williamsburg BioProcessing Foundation. Minutes. Ref Type: Report. 2002. p. 1-8.
20. McGrath M., Witte O., Pincus T., and Weissman I.L. Retrovirus purification: method that conserves envelope glycoprotein and maximises infectivity. J Virol 25 (1978) 923-927
21. Huyghe B.G., Liu X., Sutjipto S., Sugarman B.J., Horn M.T., Shepard H.M., et al. Purification of a type 5 recombinant adenovirus encoding human p53 by column chromatography. Hum Gene Ther 6 (1995) 1403-1416
22. O'Neil P.F., and Balkovic E.S. Virus harvesting and affinity-based liquid chromatography-A method for virus concentration and purification. Bio/Technol 11 (1993) 173-178
23. Klyushnichenko V., Bernier A., Kamen A., and Harmsen E. Improved high-performance liquid chromatographic method in the analysis of adenovirus particles. J Chromatogr B 755 (2001) 27-36
24. Walker S.G., and Lyddiatt A. Processing of nanoparticulate bioproducts: application and optimisation of aqueous two-phase systems. J Chem Technol Biotechnol 74 (1999) 250-255
25. Przybycien T.D., Pujar N.S., and Steele L.M. Alternative bioseparation operations: life beyond packed-bed chromatography. Curr Opin Biotechnol 15 (2004) 469-478
26. Schuegerl K., and Hubbuch J. Integrated bioprocess. Curr Opin Microbiol 8 (2005) 294-300
27. Aguilar O., Albiter V., Serrano-Carreon L., and Rito-Palomares M. Direct comparison between ion-exchange chromatography and aqueous two-phase processes for the partial purification of penicillin acylase produced by E. coli. J Chromatogr B 835 (2006) 77-83
28. Gueret V., Negrete-Virgen J.A., Lyddiatt A., and Al-Rubeai M. Rapid titration of adenoviral infectivity by flow cytometry in batch culture of infected HEK293 cells. Cytotechnology 38 (2002) 87-97
29. Sajc L., Grubisic D., and Vunjak-Novakovic G. Bioreactors for plant engineering: an outlook for further research. Biochem Eng J 4 (2000) 89-99
30. Shabram P., Vellekamp G., and Scandella C. Purification of adenovirus. In: Curiel D.T., and Douglas J.T. (Eds). Adenoviral vectors for gene therapy (2002), Academic Press, San Diego 167-203
31. Shenk T. Adenoviridae: the viruses and their replication. In: Fields B.N., Knipe D.M., and Howley P.M. (Eds). Virology (1996), Lippincott-Raven, Philadelphia 2111-2148
32. Hodgson C.P. The vector void in gene therapy. Biotechnology (N.Y.) 13 (1995) 222-225
33. Schoofs G., Monica T.J., Ayala J., Horwitz T., Montgomery T., Roth G., et al. A high-yielding serum-free, suspension cell culture process to manufacture recombinant adenoviral vectors for gene therapy. Cytotechnology 28 (1998) 81-89
34. Huddleston J., Veide A., Köhler K., Flanagan J., Enfors S.O., and Lyddiatt A. The molecular basis of partitioning in aqueous two-phase systems. TIBTECH 9 (1991) 381-388